Westover Capital Advisors’s Celgene Corp CELG Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2018
Q1
Sell
-17,912
Closed -$1.87M 127
2017
Q4
$1.87M Sell
17,912
-1,504
-8% -$170K 1.03% 36
2017
Q3
$2.83M Buy
19,416
+2,894
+18% +$394K 1.67% 20
2017
Q2
$2.15M Buy
16,522
+552
+3% +$67.6K 1.41% 28
2017
Q1
$1.99M Sell
15,970
-230
-1% -$27.5K 1.32% 28
2016
Q4
$1.88M Buy
16,200
+7,946
+96% +$885K 1.34% 28
2016
Q3
$863K Buy
+8,254
New +$893K 0.64% 53

Other funds holding CELG

Westover Capital Advisors's CELG Position: Q1 2018 in Review

Westover Capital Advisors sold out of Celgene Corp (CELG) in Q1 2018, closing a stake of 17,912 shares — an estimated $1.87M sold.

Westover Capital Advisors first reported a position in CELG in Q3 2016 and held it in 6 quarters. The position peaked at $2.83M in Q3 2017. 1,397 funds tracked by Wall St. Rank hold CELG as of Q1 2018.

  • Westover Capital Advisors reported no remaining Celgene Corp position as of Q1 2018 after selling out during the quarter.
  • Westover Capital Advisors sold 17,912 Celgene Corp shares in Q1 2018, an estimated $1.87M.
  • Westover Capital Advisors first reported a position in Celgene Corp in Q3 2016 and held it in 6 quarters.
  • Westover Capital Advisors's Celgene Corp position peaked at $2.83M in Q3 2017.
  • 1,397 funds tracked by Wall St. Rank held Celgene Corp as of Q1 2018.

Based on Westover Capital Advisors's 13F filing for Q1 2018, filed 11 May 2018.